Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 369

Similar articles for PubMed (Select 23246055)


Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.

Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Kron IL, Kern JA.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):566-73; discussion 573-4. doi: 10.1016/j.jtcvs.2012.10.034. Epub 2012 Dec 13.


Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.


Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.

Kamdar F, John R, Eckman P, Colvin-Adams M, Shumway SJ, Liao K.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):575-81. doi: 10.1016/j.jtcvs.2012.09.095.


Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failure.

Pulikottil-Jacob R, Suri G, Connock M, Kandala NB, Sutcliffe P, Maheswaran H, Banner NR, Clarke A.

J Heart Lung Transplant. 2014 Apr;33(4):350-8. doi: 10.1016/j.healun.2014.01.003. Epub 2014 Jan 19.


Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.

Arnaoutakis GJ, George TJ, Kilic A, Weiss ES, Russell SD, Conte JV, Shah AS.

J Thorac Cardiovasc Surg. 2011 Nov;142(5):1236-45, 1245.e1. doi: 10.1016/j.jtcvs.2011.07.019. Epub 2011 Aug 11.


The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.

Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. Review.


Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation.

Moreno SG, Novielli N, Cooper NJ.

J Heart Lung Transplant. 2012 May;31(5):450-8. doi: 10.1016/j.healun.2011.10.017. Epub 2011 Nov 23.


Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.

Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, Massey T, Milano CA, Moazami N, Sundareswaran KS, Farrar DJ; HeartMate II Clinical Investigators.

J Thorac Cardiovasc Surg. 2010 May;139(5):1316-24. doi: 10.1016/j.jtcvs.2009.11.020. Epub 2010 Feb 4.


Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.


Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients.

Alba AC, Alba LF, Delgado DH, Rao V, Ross HJ, Goeree R.

Circulation. 2013 Jun 18;127(24):2424-35. doi: 10.1161/CIRCULATIONAHA.112.000194. Epub 2013 May 22.


Cost of 1-year left ventricular assist device destination therapy in chronic heart failure: a comparison with heart transplantation.

Droogne W, Jacobs S, Van den Bossche K, Verhoeven J, Bostic RR, Vanhaecke J, Van Cleemput J, Rega F, Meyns B.

Acta Clin Belg. 2014 Jun;69(3):165-70. doi: 10.1179/2295333714Y.0000000017. Epub 2014 Mar 20.


Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices.

John R, Liao K, Kamdar F, Eckman P, Boyle A, Colvin-Adams M.

J Thorac Cardiovasc Surg. 2010 Aug;140(2):447-52. doi: 10.1016/j.jtcvs.2010.03.006.


Heart transplant and left ventricular assist device costs.

Digiorgi PL, Reel MS, Thornton B, Burton E, Naka Y, Oz MC.

J Heart Lung Transplant. 2005 Feb;24(2):200-4.


Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries.

Hernandez AF, Shea AM, Milano CA, Rogers JG, Hammill BG, O'Connor CM, Schulman KA, Peterson ED, Curtis LH.

JAMA. 2008 Nov 26;300(20):2398-406. doi: 10.1001/jama.2008.716.


Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).

Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, Russell SD, Conte JV, Aaronson KD, McGee EC Jr, Cotts WG, DeNofrio D, Pham DT, Farrar DJ, Pagani FD.

J Am Coll Cardiol. 2011 May 10;57(19):1890-8. doi: 10.1016/j.jacc.2010.10.062. Erratum in: J Am Coll Cardiol. 2011 Nov 8;58(20):2142.


Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices.

Maltais S, Topilsky Y, Tchantchaleishvili V, McKellar SH, Durham LA, Joyce LD, Daly RC, Park SJ.

J Thorac Cardiovasc Surg. 2012 Jun;143(6):1370-6. doi: 10.1016/j.jtcvs.2011.07.014. Epub 2011 Aug 11.


Use of left ventricular assist device (HeartMate II): a Singapore experience.

Lim CP, Sivathasan C, Tan TE, Lim CH, Kerk KL, Sim DK.

Artif Organs. 2014 Jul;38(7):543-8. doi: 10.1111/aor.12247. Epub 2014 Jan 7.


Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.

Long EF, Swain GW, Mangi AA.

Circ Heart Fail. 2014 May;7(3):470-8. doi: 10.1161/CIRCHEARTFAILURE.113.000807. Epub 2014 Feb 21.


Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure: analysis of the British NHS bridge to transplant (BTT) program.

Clarke A, Pulikottil-Jacob R, Connock M, Suri G, Kandala NB, Maheswaran H, Banner NR, Sutcliffe P.

Int J Cardiol. 2014 Feb 15;171(3):338-45. doi: 10.1016/j.ijcard.2013.12.015. Epub 2013 Dec 18.


Device exchange after primary left ventricular assist device implantation: indications and outcomes.

Stulak JM, Cowger J, Haft JW, Romano MA, Aaronson KD, Pagani FD.

Ann Thorac Surg. 2013 Apr;95(4):1262-7; discussion 1267-8. doi: 10.1016/j.athoracsur.2012.08.031. Epub 2012 Oct 11.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk